Ichnos Sciences | ApexOnco - Clinical Trials news and analysis

x

“OncologyPipeline is my favorite CI tool”

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Conferences Trial results

4 June 2025

ASCO 2025 – J&J challenges its own multiple myeloma T-cell engagers

Meanwhile, Ichnos Glenmark takes a different trispecific multiple myeloma approach.

Subscribe to Ichnos Sciences